Skip to main content
Retour
Watch Compare

Aptose Biosciences Inc.

Qualité des données : 83%
APTOF
OTC Manufacturing Chemicals
1,72 €
▲ 0,01 € (0,58%)
Cap. Boursière: 4,41 M
Prix
1,71 €
Cap. Boursière
4,41 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -21,99 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio0,53
Interest CoverageN/A

Valorisation

PE (TTM)
-0,17
Au-dessus de la moyenne du secteur (-1,47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,2 -1,5
P/B — 1,6
ROE % — -53,3
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q22025 -2,74 € -2,76 € -0,7%
Q12025 -2,67 € -2,61 € +2,3%
Q42024 -6,78 € -34,90 € -415,1%
Q32024 -19,20 € -11,10 € +42,2%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -25,47 M
ROE N/A ROA -426,89%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -21,99 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,53
Interest Coverage N/A Asset Turnover N/A
Working Capital -3,30 M Tangible Book Value -19,45 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,17 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -498,66%
Market Cap 4,41 M Enterprise Value 3,80 M
Per Share
EPS (Diluted TTM) -10,41 Revenue / Share N/A
FCF / Share -8,53 OCF / Share -8,53
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 86,34%
SBC-Adj. FCF -22,41 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -25,47 M -25,43 M -51,21 M -41,82 M -65,35 M
EPS (Diluted) -10,41 -36,38 -7,58 -0,45 —
Gross Profit — — — — —
Operating Income — — — — —
EBITDA — — — — —
R&D Expenses 11,34 M 15,10 M 33,27 M 28,09 M 45,99 M
SG&A Expenses — — — — —
D&A — — 88 000,0 120 000,0 150 000,0
Interest Expense — — — — —
Income Tax 0,0 0,0 — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 10,01 M 10,13 M 12,99 M 51,03 M 82,53 M
Total Liabilities 37,18 M 14,67 M 15,89 M 13,29 M 8,29 M
Shareholders' Equity -27,17 M -4,54 M -2,90 M 37,74 M 74,24 M
Total Debt — — — — —
Cash & Equivalents 935 000,0 6,15 M 9,25 M 36,97 M 39,11 M
Current Assets 6,45 M 9,53 M 11,89 M 49,52 M 81,74 M
Current Liabilities 9,31 M 4,46 M 15,27 M 12,28 M 8,17 M